Sichuan Credit Chemwerth Pharmaceutical Co., Ltd (Credit-Chemwerth) was founded in 2007. It is specializing in researching, developing and manufacturing APIs and intermediates. The company had acquired China GMP certificate (2010 version), and passed US FDA inspection twice.
Credit-Chemwerth is a Sino–US joint venture company established by Sichuan Credit Pharmaceutical Co., Ltd and Chemwerth Inc. The company not only provides APIs for holding company, but also provides intermediates and APIs for both domestic and international pharmaceutical companies.
The products mainly are sold in domestics market as well as in EU and USA. The company is engaging in developing on new market, e.g. Japan, Korea, Middle East, South America, etc.
Credit-Chemwerth is a Sino–US joint venture company established by Sichuan Credit Pharmaceutical Co., Ltd and Chemwerth Inc. The company not only provides APIs for holding company, but also provides intermediates and APIs for both domestic and international pharmaceutical companies.
The products mainly are sold in domestics market as well as in EU and USA. The company is engaging in developing on new market, e.g. Japan, Korea, Middle East, South America, etc.
